See all results for ""

Bhavik Narsana

, Mumbai

Partner | Corporate and Commercial, Private Equity, Pharmaceuticals


  • Solicitor, Mumbai (2003)
  • LL.B., University of Mumbai (2001)

Bhavik Narsana is a Partner in the Corporate and Commercial Practice Group in the Mumbai office. Bhavik’s expertise lies in corporate transactions including mergers and acquisitions, private equity and strategic investments, joint ventures, involving both listed and unlisted target companies and cross-border transactions.

Professional Affiliations

  • The Bombay Incorporated Law Society
  • Bar Council of Maharashtra & Goa

Recognition and Accomplishments

  • Acknowledged for his experience and expertise by IFLR 1000 for lawyer rankings 2019 as a Notable Practitioner in M&A transactions.I
  • Acknowledged by FLR 1000 for lawyer rankings 2019 as a Notable Practitioner in M&A transactions.

Representative Matters

Bhavik Narsana has represented and advised the following clients

Cadila Healthcare Limited and Zydus Wellness Limited

Advised on the acquisition of 100% shareholding of Heinz India Private Limited (with Complan, Glucon-D, Nycil and Sampriti).

L N Bangur Group

Advised on (i) their investment in Parag Milk Foods Limited, (ii) their investment in Suryoday Micro Finance Limited, (iii) their investment in Goldsquare Sales India Private Limited (Fashion & You), and (iv) sale of their stake in The Andhra Pradesh Paper Mills Limited to International Papers.

Torrent Pharmaceuticals Limited

Advised on acquisition of domestic pharmaceuticals formulations business from Unichem Laboratories Limited.

Otsuka Pharmaceuticals Limited

Advised on joint venture with Mitsui & Co. Limited and Claris Lifesciences Limited.

Advent International

Advised on investment in Quality Care India Limited.

Lenskart (Valyoo Technologies Private Limited)

Advised on investments by TPG Group, IDG Ventures and others.

Avendus Capital Private Limited and its promoters

Advised on the investment made by Eastgate Gems SPV 4-S.

Elder Pharmaceuticals Limited

Advised on sale of business to Torrent Pharmaceuticals Limited.

Pepe Group

Advised on various investments in India.


iconExternal Links

10 Jul '20
CSR: Normal course of business in times of COVID-19


17 Jun '20
Funding Options For Chinese-Backed Indian Companies


29 May '20
Foreign Investors’ downstream investment

iconErgo Update

31 Mar '20
Telemedicine Practice Guidelines

iconErgo Update

27 Feb '20
All medical devices notified to be regulated

News and Events

Bhavik Narsana has featured in the following news and webinars

Similar profiles